Jignesh M. Doshi, Ph.D. - Publications
Affiliations: | 2008 | Medicinal Chemistry | University of Minnesota, Twin Cities, Minneapolis, MN |
Area:
Pharmaceutical Chemistry, Organic ChemistryYear | Citation | Score | |||
---|---|---|---|---|---|
2011 | Das SG, Srinivasan B, Hermanson DL, Bleeker NP, Doshi JM, Tang R, Beck WT, Xing C. Structure-activity relationship and molecular mechanisms of ethyl 2-amino-6-(3,5-dimethoxyphenyl)-4-(2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (CXL017) and its analogues. Journal of Medicinal Chemistry. 54: 5937-48. PMID 21780800 DOI: 10.1021/Jm200764T | 0.609 | |||
2009 | Das SG, Doshi JM, Tian D, Addo SN, Srinivasan B, Hermanson DL, Xing C. Structure-activity relationship and molecular mechanisms of ethyl 2-amino-4-(2-ethoxy-2-oxoethyl)-6-phenyl-4h-chromene-3-carboxylate (sha 14-1) and its analogues. Journal of Medicinal Chemistry. 52: 5937-49. PMID 19743858 DOI: 10.1021/Jm9005059 | 0.62 | |||
2008 | Tian D, Das SG, Doshi JM, Peng J, Lin J, Xing C. sHA 14-1, a stable and ROS-free antagonist against anti-apoptotic Bcl-2 proteins, bypasses drug resistances and synergizes cancer therapies in human leukemia cell. Cancer Letters. 259: 198-208. PMID 18037229 DOI: 10.1016/J.Canlet.2007.10.012 | 0.652 | |||
2008 | Doshi JM, Xing C. Antagonists against anti-apoptotic Bcl-2 family proteins for cancer treatment Mini-Reviews in Organic Chemistry. 5: 171-178. DOI: 10.2174/157019308785161639 | 0.63 | |||
2007 | Doshi JM, Tian D, Xing C. Ethyl-2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H- chromene-3-carboxylate (HA 14-1), a prototype small-molecule antagonist against antiapoptotic Bcl-2 proteins, decomposes to generate reactive oxygen species that induce apoptosis. Molecular Pharmaceutics. 4: 919-28. PMID 17874842 DOI: 10.1021/Mp7000846 | 0.585 | |||
2006 | Doshi JM, Tian D, Xing C. Structure-activity relationship studies of ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (HA 14-1), an antagonist for antiapoptotic Bcl-2 proteins to overcome drug resistance in cancer. Journal of Medicinal Chemistry. 49: 7731-9. PMID 17181155 DOI: 10.1021/Jm060968R | 0.615 | |||
Show low-probability matches. |